Candida vaginitis: virulence, host response and vaccine prospects.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Medical Mycology

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/mmy/myx139PMID 29538739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.

  2017cited by this paper
• Candida vulvovaginitis: A store with a buttery and a show window

  2017cited by this paper
• Candida albicans Agglutinin-Like Sequence (Als) Family Vignettes: A Review of Als Protein Structure and Function

  2016cited by this paper
• Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework

  2016cited by this paper
• Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC

  2016cited by this paper
• Aspartyl Proteinases of Eukaryotic Microbial Pathogens: From Eating to Heating

  2016cited by this paper
• Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota

  2016cited by this paper
• Experimental Models of Vaginal Candidiasis and Their Relevance to Human Candidiasis

  2016cited by this paper
• Editorial Commentary: Vaginal Biofilm: Much Ado About Nothing, or a New Therapeutic Challenge?

  2015cited by this paper
• Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections.

  2015cited by this paper
• Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface

  2015cited by this paper
• Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice

  2015cited by this paper
• Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects

  2015cited by this paper
• H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

  2014cited by this paper
• Candida Vaginitis: When Opportunism Knocks, the Host Responds

  2014cited by this paper
• Candida antigens and immune responses: implications for a vaccine

  2014cited by this paper
• Recurrent vulvovaginitis.

  2014cited by this paper
• Candida albicans pathogenicity mechanisms

  2013cited by this paper
• Niche-Specific Requirement for Hyphal Wall protein 1 in Virulence of Candida albicans

  2013cited by this paper
• Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States: Results From an Internet Panel Survey

  2013cited by this paper
• Genetic susceptibility to Candida infections

  2013cited by this paper
• IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis

  2013cited by this paper
• Development of vaccines for Candida albicans: fighting a skilled transformer

  2013cited by this paper
• Fungal Morphogenetic Pathways Are Required for the Hallmark Inflammatory Response during Candida albicans Vaginitis

  2013cited by this paper
• Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women

  2013cited by this paper
• Fungal cell wall vaccines: an update

  2012cited by this paper
• A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.

  2012cited by this paper
• Fungal cell wall vaccines: an update.

  2012cited by this paper
• Recent progress in vaccines against fungal diseases.

  2012cited by this paper
• Candida and candidiasis.

  2012cited by this paper
• Candida albicans dimorphism as a therapeutic target

  2012cited by this paper
• Relation of ALS 1 and ALS3 genes and fluconazole resistance in Candida albicans isolated from vaginal candidacies

  2012cited by this paper
• From memory to antifungal vaccine design.

  2012cited by this paper
• Fluconazole-Resistant Candida albicans Vulvovaginitis

  2012cited by this paper
• NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

  2012cited by this paper
• Candida albicans Yeast and Hyphae are Discriminated by MAPK Signaling in Vaginal Epithelial Cells

  2011cited by this paper
• Growth of Candida albicans hyphae

  2011cited by this paper
• Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis

  2011cited by this paper
• A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.

  2011cited by this paper
• An insight into the antifungal pipeline: selected new molecules and beyond

  2010cited by this paper
• A Multifunctional Mannosyltransferase Family in Candida albicans Determines Cell Wall Mannan Structure and Host-Fungus Interactions

  2010cited by this paper
• Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.

  2010cited by this paper
• Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

  2010cited by this paper
• Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.

  2010cited by this paper
• Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights

  2010cited by this paper
• Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.

  2009cited by this paper
• The iC3b receptor of Candida albicans and its roles in pathogenesis.

  2008cited by this paper
• Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit.

  2008cited by this paper
• Fungal vaccines: real progress from real challenges.

  2008cited by this paper
• Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis

  2008cited by this paper
• Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.

  2007cited by this paper
• The 65 kDa mannoprotein gene of Candida albicans encodes a putative β‐glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity

  2007cited by this paper
• Vulvovaginal candidosis.

  2007cited by this paper
• History and Update on Host Defense Against Vaginal Candidiasis

  2007cited by this paper
• Advances in combating fungal diseases: vaccines on the threshold

  2007cited by this paper
• In vivo and ex vivo comparative transcriptional profiling of invasive and non‐invasive Candida albicans isolates identifies genes associated with tissue invasion

  2007cited by this paper
• Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.

  2006cited by this paper
• Phenotypic and Functional Characterization of Vaginal Dendritic Cells in a Rat Model of Candida albicans Vaginitis

  2006cited by this paper
• Recurrent vulvovaginal candidiasis.

  2006cited by this paper
• Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.

  2006cited by this paper
• Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.

  2006cited by this paper
• Management of recurrent vulvovaginal candidiasis: Unresolved issues

  2006cited by this paper
• The epidemiology of mycotic vulvovaginitis and the use of antifungal agents in suspected mycotic vulvovaginitis and its implications for clinical practice.

  2005cited by this paper
• Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

  2005cited by this paper
• Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis.

  2005cited by this paper
• Contributions of hyphae and hypha‐co‐regulated genes to Candida albicans virulence

  2005cited by this paper
• Hydrolytic enzymes as virulence factors of Candida albicans

  2005cited by this paper
• Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

  2004cited by this paper
• The distinct morphogenic states of Candida albicans.

  2004cited by this paper
• From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans.

  2004cited by this paper
• Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection

  2003cited by this paper
• Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis

  2003cited by this paper
• Vulvovaginal candidiasis.

  2003cited by this paper
• Adhesion in Candida spp

  2002cited by this paper
• Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors

  2002cited by this paper
• Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women.

  2002cited by this paper
• The Unique Solution Structure and Immunochemistry of theCandida albicans β-1,2-Mannopyranan Cell Wall Antigens* 210

  2002cited by this paper
• Pathogenesis of recurrent vulvovaginal candidiasis

  2002cited by this paper
• Aspartyl proteinases of Candida albicans and their role in pathogenicity.

  2001cited by this paper
• The ALS gene family of Candida albicans.

  2001cited by this paper
• Virulence factors of Candida albicans.

  2001cited by this paper
• Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans

  2000cited by this paper
• Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

  1999cited by this paper
• Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.

  1999cited by this paper
• Human vaginal mucosal immune system: characterization and function.

  1998cited by this paper
• Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.

  1998cited by this paper
• Nonfilamentous C. albicans mutants are avirulent.

  1997cited by this paper
• Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats

  1997cited by this paper
• Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis

  1995cited by this paper
• Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection

  1995cited by this paper
• Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis

  1994cited by this paper
• Recurrent vulvovaginal candidiasis.

  1987cited by this paper

• Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

  2026cites this paper
• Sporothrix brasiliensis and cats: understanding the disease and the promising potential of veterinary antifungal vaccination for a healthier future of both humans and animals

  2025cites this paper
• A comprehensive review of neurotropic fungal infections: clinical manifestations and vaccines

  2025cites this paper
• Mucosal immune response modulated by secreted and membrane-bound hydrolases of Candida albicans in vulvovaginal candidiasis

  2025cites this paper
• Advances in fungal vaccine development: Progress in the face of emerging challenges

  2025cites this paper
• New antifungal strategies and drug development against WHO critical priority fungal pathogens

  2025cites this paper
• Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects

  2025cites this paper
• Understanding the mechanisms of resistance to azole antifungals in Candida species

  2025cites this paper
• Mechanism of recombinant 1,3-β-glucanase as antibiofilm to prevent antimicrobial resistance in antifungal therapy for vulvovaginitis candidiasis

  2025influential citation
• The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis

  2025cites this paper
• Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies

  2025cites this paper
• Development and Validation of Ultraviolet Spectroscopic Method for Estimation of Voriconazole in Bulk and Pharmaceutical Formulation

  2025cites this paper
• The Fungal Susceptibility Mechanism of Inborn Errors of Immunity and Novel Antifungal Therapies

  2025cites this paper
• Preparation and evaluation of vaginal suppo-sponges loaded with benzydamine, in-vitro/in-vivo study

  2024cites this paper
• The Antifungal Potential of Ozonated Extra-Virgin Olive Oil Against Candida albicans: Mechanisms and Efficacy

  2024cites this paper
• Homogeneous synthesis of cationic celluloses with broad-spectrum antibacterial activities for the treatment of vaginitis in mice.

  2024cites this paper
• Pulsatilla suppository prevents recurrent vulvovaginal candidiasis in a rat model via the TLR/MyD88/NLRP3 signaling pathway.

  2024cites this paper
• Invasive Mykosen – Innovative Therapien

  2024cites this paper
• Invasive Mykosen – Innovative Therapien

  2024cites this paper
• Vagina, a promising route for drug delivery

  2024cites this paper
• Relationship between vaginal microecology and human papillomavirus infection as well as cervical intraepithelial neoplasia in 2,147 women from Wenzhou, the southeast of China

  2024cites this paper
• Lacticaseibacillus rhamnosus CA15 (DSM 33960) strain as a new driver in restoring the normal vaginal microbiota: A randomized, double-blind, placebo-controlled clinical trial

  2023cites this paper
• Anti-Staphylococcal, Anti-Candida, and Free-Radical Scavenging Potential of Soil Fungal Metabolites: A Study Supported by Phenolic Characterization and Molecular Docking Analysis

  2023cites this paper
• Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges

  2023cites this paper
• Protection against lethal sepsis following immunization with Candida species varies by isolate and inversely correlates with bone marrow tissue damage

  2023cites this paper
• Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics

  2023cites this paper
• The effect of herbal medicine in innate immunity to Candida albicans

  2023cites this paper
• Fungal infections: Immune defense, immunotherapies and vaccines.

  2023cites this paper
• Immune responses to human fungal pathogens and therapeutic prospects

  2023cites this paper
• Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span

  2022cites this paper
• Determination of fungal and parasitic infections caused vaginitis: molecular identification of Candida parapsilosis in Al-Nasiriyah city, Iraq

  2022cites this paper
• Humoral immune responses against facultative pathogen Candida utilis in atopic patients with vulvovaginal candidiasis. Candida utilis glucomannan - New serologic biomarker.

  2021cites this paper
• University of Birmingham Immune Sensing of Candida albicans

  2021cites this paper
• Risk factors associated with the persistence of human papillomavirus after cervical excision in patients with high-grade squamous intra-epithelial neoplasia.

  2021cites this paper
• Prospects for anti-Candida therapy through targeting the cell wall: A mini-review

  2021cites this paper
• Candida Pathogenicity and Interplay with the Immune System.

  2021cites this paper
• Symbiosis and Dysbiosis of the Human Mycobiome

  2021cites this paper
• Virulence Factors as Promoters of Chronic Vulvovaginal Candidosis: A Review

  2021cites this paper
• Risk factors associated with HPV persistence after conization in high-grade squamous intraepithelial lesion

  2021cites this paper
• Antimicrobial immunotherapeutics: past, present and future.

  2021cites this paper
• Candidíase e candidemia neonatal: Revisão de literatura

  2021cites this paper
• It Takes Two to Tango: How a Dysregulation of the Innate Immunity, Coupled With Candida Virulence, Triggers VVC Onset

  2021cites this paper
• Antagonistic Effects of Lactobacillus plantarum on Candida albicans in ME-180 Cervical Carcinoma Cell Culture

  2021cites this paper
• Vaccines for human fungal diseases: close but still a long way to go

  2021cites this paper
• In vivo study of hypericin-loaded poloxamer-based mucoadhesive in situ gelling liquid crystalline precursor system in a mice model of vulvovaginal candidiasis.

  2021cites this paper
• Immune Sensing of Candida albicans

  2021cites this paper
• Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice

  2021cites this paper
• Protective effect of fungal extracellular vesicles against murine candidiasis.

  2020cites this paper
• Caracterização sistemática da resposta imune à infecção por Candida

  2020cites this paper
• Nanoparticle-based vaccines

  2020cites this paper
• Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis

  2020cites this paper
• PGPM_A_275073 725..733

  2020cites this paper
• The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives

  2020cites this paper
• Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population

  2020cites this paper
• Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response

  2020cites this paper
• Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis

  2020cites this paper
• Advances in Vaccine Development Against Sporotrichosis

  2019cites this paper
• Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.

  2019cites this paper
• A performance evaluation of an immuno-latex chromatography card for the rapid detection of Candida spp.

  2019cites this paper
• Fungal-Bacterial Interactions in Health and Disease

  2019cites this paper
• Looking for appropriateness in the cure of mixed vaginitis: the role of fenticonazole as an empiric treatment.

  2019cites this paper
• Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients

  2019cites this paper
• Functional Synergy Of Antimicrobial Peptides And Chlorhexidine Acetate Against Gram-Negative/Gram-Positive Bacteria And A Fungus In Vitro And In Vivo

  2019cites this paper
• Advances in Vaccine Development Against Sporotrichosis

  2019cites this paper
• Candidemia in the cancer patient: diagnosis, treatment, and future directions

  2018cites this paper